首页> 外文期刊>Materials Letters >Bioactive monolithic composites of silica/polydimethylsiloxane/calcium phosphate obtained at room temperature in sol-gel micromolding technique
【24h】

Bioactive monolithic composites of silica/polydimethylsiloxane/calcium phosphate obtained at room temperature in sol-gel micromolding technique

机译:溶胶-凝胶微模塑技术在室温下获得二氧化硅/聚二甲基硅氧烷/磷酸钙的生物活性整体复合材料

获取原文
获取原文并翻译 | 示例
           

摘要

In this work, the novel silica/polydimethylsiloxane/calcium phosphate composites (70%Si20%PDMS10% CaP and 60%Si20%PDMS20%CaP) were prepared in the sol-gel process combined with micromolding technique at room temperature. The self-formation rate of carbonate hydroxyapatite on the composites surface was examined under in vitro biomimetic conditions. Results showed the progressive increase in the surface mineralisation ability for 70%Si20%PDMS10%CaP composite and the retarded initial mineralisation promotion for the 60%Si20%PDMS20%CaP composite. In contrast, model drug release (doxorubicin) form the 60%Si20%PDMS20%CaP was slower compared to 70%Si20%PDMS10%CaP composite. This low temperature sol-gel micromolding process may lead to novel silica/polydimethylsiloxane/calcium phosphate composites with potential application as smart filling scaffolds in bone surgery with the possible loading of drug molecules. (C) 2016 Elsevier B.V. All rights reserved.
机译:在这项工作中,新型的二氧化硅/聚二甲基硅氧烷/磷酸钙复合材料(70%Si20%PDMS10%CaP和60%Si20%PDMS20%CaP)通过溶胶-凝胶法结合微成型技术在室温下制备。在体外仿生条件下,检查了复合材料表面碳酸盐羟基磷灰石的自形成速率。结果表明,70%Si20%PDMS10%CaP复合材料的表面矿化能力逐渐提高,而60%Si20%PDMS20%CaP复合材料的初始矿化促进受到延迟。相比之下,与70%Si20%PDMS10%CaP复合材料相比,由60%Si20%PDMS20%CaP释放的模型药物(阿霉素)的速度较慢。这种低温溶胶-凝胶微成型工艺可能会导致新型的二氧化硅/聚二甲基硅氧烷/磷酸钙复合材料,具有潜在的应用潜力,可以在骨外科中用作智能填充支架,并可能负载药物分子。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号